RETRACTION: Reduced interleukin-38 in non-small cell lung cancer is associated with tumour progression (Retraction of Vol 8, Pg 49064, 2017)

被引:0
|
作者
Wang, Feng
Zhang, Weihua
Wu, Tianfeng
Chu, Heying
机构
关键词
D O I
10.1098/rsob.200204
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Reduced interleukin-38 in non-small cell lung cancer is associated with tumour progression (Expression of Concern of Vol 8, art no 180132, 2018)
    Wang, Feng
    Zhang, Weihua
    Wu, Tianfeng
    Chu, Heying
    OPEN BIOLOGY, 2020, 10 (06)
  • [2] RETRACTED: Reduced interleukin-38 in non-small cell lung cancer is associated with tumour progression (Publication with Expression of Concern. See vol. 10, 2020) (Retracted Article)
    Wang, Feng
    Zhang, Weihua
    Wu, Tianfeng
    Chu, Heying
    OPEN BIOLOGY, 2018, 8 (10)
  • [3] RETRACTION: Reduced miR-125a-5p level in non-small-cell lung cancer is associated with tumour progression (Retraction of Vol 8, art no 180118, 2018)
    Liu, Hongxu
    Ma, Yegang
    Liu, Changhao
    Li, Pengfei
    Yu, Tao
    OPEN BIOLOGY, 2020, 10 (07)
  • [4] RETRACTION: MicroRNA-616 promotes the growth and metastasis of non-small cell lung cancer by targeting SOX7 (Retraction of Vol 38, Pg 2078, 2017)
    Wang, Danping
    Cao, Qifeng
    Qu, Meijun
    Xiao, Zhaoqun
    Zhang, Minghui
    Di, Songbo
    ONCOLOGY REPORTS, 2023, 50 (04)
  • [5] RETRACTION: Implication of BIS in the Migration and Invasion of A549 Non-small Cell Lung Cancer Cells (Retraction of Vol 38, Pg 5057, 2018)
    Yun, Hye Hyeon
    Kim, Seulki
    Ji, Sang Hee
    Kuh, Hyo-Jeong
    Lee, Jeong-Hwa
    ANTICANCER RESEARCH, 2018, 38 (10) : 6027 - 6027
  • [6] RETRACTION: PART1 expression is associated with poor prognosis and tumor recurrence in stage I-III non-small cell lung cancer (Retraction of Vol 8, Pg 1795, 2017)
    Li, Ming
    Zhang, Weiwei
    Zhang, Shenjun
    Wang, Changhui
    Lin, Yinping
    JOURNAL OF CANCER, 2023, 14 (08): : 1335 - 1335
  • [7] RETRACTION: The miR-599 promotes non-small cell lung cancer cell invasion via SATB2 (Retraction of Vol 485, Pg 35, 2017)
    Tian, Wenjun
    Wang, Guanghai
    Liu, Yiqing
    Huang, Zhenglan
    Zhang, Caiqing
    Ning, Kang
    Yu, Cuixiang
    Shen, Yajuan
    Wang, Minghui
    Li, Yuantang
    Wang, Yong
    Zhang, Bing Chang
    Zhao, Yaoran
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 515 (04) : 733 - 733
  • [8] RETRACTION: MicroRNA-381 serves as a prognostic factor and inhibits migration and invasion in non-small cell lung cancer by targeting LRH-1 (Retraction of Vol 38, Pg 3071, 2017)
    Tian, Chunyan
    Li, Jun
    Ren, Lili
    Peng, Ren
    Chen, Binbin
    Lin, Yumei
    ONCOLOGY REPORTS, 2023, 50 (05) : 203 - 203
  • [9] RETRACTION: MACC-1 antibody target therapy suppresses growth and migration of non-small cell lung cancer (Retraction of Vol 16, Pg 7329, 2017)
    Shi, Woda
    Song, Jianxiang
    Wang, Wencai
    Zhang, Yajun
    Zheng, Shiying
    MOLECULAR MEDICINE REPORTS, 2024, 29 (01)
  • [10] RETRACTION: Prognosis and Biological Function of miR-3195 in Non-Small Cell Lung Cancer (Retraction of Vol 14, Pg 169, 2022)
    Lu, Y.
    Zhang, X.
    Zhang, H.
    Zhu, Z.
    CANCER MANAGEMENT AND RESEARCH, 2023, 15 : 1265 - 1265